PubMed:25305591 / 411-755 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T3","span":{"begin":0,"end":344},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":344},"obj":"Sentence"}],"text":"Although these peptides have been repeatedly shown to exert potent anti-inflammatory actions when administered in animal models of inflammatory disease, mice deficient in VIP and PACAP were recently shown to exhibit different phenotypes (ameliorated and exacerbated, respectively) in response to experimental autoimmune encephalomyelitis (EAE)."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T2","span":{"begin":0,"end":344},"obj":"DRI_Background"}],"text":"Although these peptides have been repeatedly shown to exert potent anti-inflammatory actions when administered in animal models of inflammatory disease, mice deficient in VIP and PACAP were recently shown to exhibit different phenotypes (ameliorated and exacerbated, respectively) in response to experimental autoimmune encephalomyelitis (EAE)."}

{"project":"TEST-DiseaseOrPhenotypicFeature","denotations":[{"id":"T2","span":{"begin":296,"end":337},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":339,"end":342},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"#label","subj":"T2","obj":"D004681"},{"id":"A3","pred":"#label","subj":"T3","obj":"D004681"}],"text":"Although these peptides have been repeatedly shown to exert potent anti-inflammatory actions when administered in animal models of inflammatory disease, mice deficient in VIP and PACAP were recently shown to exhibit different phenotypes (ameliorated and exacerbated, respectively) in response to experimental autoimmune encephalomyelitis (EAE)."}

{"project":"TEST-ChemicalEntity","denotations":[{"id":"T5","span":{"begin":171,"end":174},"obj":"ChemicalEntity"}],"attributes":[{"id":"A5","pred":"ID:","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"}],"text":"Although these peptides have been repeatedly shown to exert potent anti-inflammatory actions when administered in animal models of inflammatory disease, mice deficient in VIP and PACAP were recently shown to exhibit different phenotypes (ameliorated and exacerbated, respectively) in response to experimental autoimmune encephalomyelitis (EAE)."}

{"project":"TEST-OrganismTaxon","denotations":[{"id":"T2","span":{"begin":153,"end":157},"obj":"OrganismTaxon"}],"text":"Although these peptides have been repeatedly shown to exert potent anti-inflammatory actions when administered in animal models of inflammatory disease, mice deficient in VIP and PACAP were recently shown to exhibit different phenotypes (ameliorated and exacerbated, respectively) in response to experimental autoimmune encephalomyelitis (EAE)."}

{"project":"Test-GeneOrGeneProduct","denotations":[{"id":"T8","span":{"begin":171,"end":174},"obj":"GeneOrGeneProduct"},{"id":"T9","span":{"begin":179,"end":184},"obj":"GeneOrGeneProduct"}],"text":"Although these peptides have been repeatedly shown to exert potent anti-inflammatory actions when administered in animal models of inflammatory disease, mice deficient in VIP and PACAP were recently shown to exhibit different phenotypes (ameliorated and exacerbated, respectively) in response to experimental autoimmune encephalomyelitis (EAE)."}

{"project":"Test-merged-2","denotations":[{"id":"T20448","span":{"begin":171,"end":174},"obj":"ChemicalEntity"},{"id":"T8","span":{"begin":171,"end":174},"obj":"GeneOrGeneProduct"},{"id":"T9","span":{"begin":179,"end":184},"obj":"GeneOrGeneProduct"},{"id":"T45131","span":{"begin":153,"end":157},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":296,"end":337},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":339,"end":342},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A5152","pred":"ID:","subj":"T20448","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"},{"id":"A2","pred":"#label","subj":"T2","obj":"D004681"},{"id":"A3","pred":"#label","subj":"T3","obj":"D004681"}],"text":"Although these peptides have been repeatedly shown to exert potent anti-inflammatory actions when administered in animal models of inflammatory disease, mice deficient in VIP and PACAP were recently shown to exhibit different phenotypes (ameliorated and exacerbated, respectively) in response to experimental autoimmune encephalomyelitis (EAE)."}

{"project":"Test-merged","denotations":[{"id":"T3","span":{"begin":339,"end":342},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":296,"end":337},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T45131","span":{"begin":153,"end":157},"obj":"OrganismTaxon"},{"id":"T9","span":{"begin":179,"end":184},"obj":"GeneOrGeneProduct"},{"id":"T20448","span":{"begin":171,"end":174},"obj":"ChemicalEntity"}],"attributes":[{"id":"A3","pred":"#label","subj":"T3","obj":"D004681"},{"id":"A2","pred":"#label","subj":"T2","obj":"D004681"},{"id":"A5152","pred":"ID:","subj":"T20448","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"}],"text":"Although these peptides have been repeatedly shown to exert potent anti-inflammatory actions when administered in animal models of inflammatory disease, mice deficient in VIP and PACAP were recently shown to exhibit different phenotypes (ameliorated and exacerbated, respectively) in response to experimental autoimmune encephalomyelitis (EAE)."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":309,"end":319},"obj":"HP_0002960"}],"text":"Although these peptides have been repeatedly shown to exert potent anti-inflammatory actions when administered in animal models of inflammatory disease, mice deficient in VIP and PACAP were recently shown to exhibit different phenotypes (ameliorated and exacerbated, respectively) in response to experimental autoimmune encephalomyelitis (EAE)."}